Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process

• Asıl Yazarlar: Mac Arturo Murillo-Fernández (Yazar), Ernesto Montero-Zeledón (Yazar), Ariadna Abdala-Saiz (Yazar), José Roberto Vega-Baudrit (Yazar), Andrea Mariela Araya-Sibaja (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2022-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

A drug-drug and drug-excipient interactions and compatibilities study was conducted for two fixed-dose combination (FDC) products containing olmesartan medoxomil (OLM)/hydrochlorothiazide (HCT) 20/12.5 mg and OLM/HCT 40/12.5 mg during their development including storage. The study consisted of the e...